Neoplasms, Kidney Completed Phase 2 Trials for Capecitabine (DB01101)

Also known as: Kidney Neoplasms / Kidney Neoplasm

IndicationStatusPhase
DBCOND0032585 (Neoplasms, Kidney)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00226980A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell CarcinomaTreatment